Article

Medication-Wide Association Study of Alzheimer’s Disease and Related Dementias: Identifying Drug Candidates from Electronic Health Records through Explainable AI

2026-06-03

Abstract excerpt

<h4>Objective</h4> Alzheimer’s disease (AD) is a leading cause of death and disability, and treatment options for Alzheimer’s disease and related dementias (ADRD) remain limited. We applied a data-driven, mechanism-agnostic Medication-Wide Association Study Plus (MWAS+) framework to identify candidate medications associated with ADRD using longitudinal electronic health record data and explainable artificial inte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a9e7c38b-594c-5abe-b67b-db634a4d4070
DOI: 10.64898/2026.06.02.26354752

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Medication-Wide Association Study of Alzheimer’s Disease and Related Dementias: Identifying Drug Candidates from Electronic Health Records through Explainable AIDOI 10.64898/2026.06.02.26354752Read

CauReL: Dynamic Counterfactual Learning for Precision Drug Repurposing in Alzheimer's DiseaseSemantic proximity Read

Integrating explainable AI with multiomics systems biology and EHR data mining for personalized drug repurposing in Alzheimer’s diseaseSemantic proximity Read

Identifying incident dementia by applying machine learning to a very large administrative claims datasetSemantic proximity Read

Predicting Risk of Alzheimer’s Diseases and Related Dementias with AI Foundation Model on Electronic Health RecordsSemantic proximity Read

Risk Stratification for In-Hospital Mortality in Alzheimer’s Disease Using Interpretable Regression and Explainable AISemantic proximity Read

Temporal Cohort Identification for Alzheimer’s Disease with Sequences of Clinical RecordsSemantic proximity Read

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine and Risperidone in Alzheimer’s Disease: A Real□World Cohort Study with Treatment Effect Heterogeneity AnalysisSemantic proximity Read

Explainable Artificial Intelligence in Precision Medicine: Methods, Applications, and ChallengesSemantic proximity Read

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical DatasetsSemantic proximity Read

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer’s, Parkinson’s and dementia at age 65: a study using medical records from France and the UK General PractitionersSemantic proximity Read

A Self-Explainable Dynamic Risk Monitoring Framework for Predicting Alzheimer’s Disease and Related DementiasSemantic proximity Read

Drug repurposing of metformin for Alzheimer’s disease: Combining causal inference in medical records data and systems pharmacology for biomarker identificationSemantic proximity Read